scholarly journals The evaluation of the anti‐cancer drug elesclomol that forms a redox‐active copper chelate as a potential anti‐tubercular drug

IUBMB Life ◽  
2019 ◽  
Vol 71 (5) ◽  
pp. 532-538 ◽  
Author(s):  
Andile H. Ngwane ◽  
Ray‐Dean Petersen ◽  
Bienyameen Baker ◽  
Ian Wiid ◽  
Ho Ning Wong ◽  
...  
Nanoscale ◽  
2018 ◽  
Vol 10 (20) ◽  
pp. 9773-9779 ◽  
Author(s):  
Devleena Samanta ◽  
Niloufar Hosseini-Nassab ◽  
Aidan D. McCarty ◽  
Richard N. Zare

Redox-active anti-cancer drugs can be released without compromising their bioactivity from polypyrrole nanoparticles that respond to ultra-low voltages (−75 mV).


Redox Report ◽  
2013 ◽  
Vol 18 (2) ◽  
pp. 48-50 ◽  
Author(s):  
Danuta S. Kalinowski ◽  
Patric J. Jansson ◽  
Zaklina Kovacevic ◽  
Des R. Richardson

Xenobiotica ◽  
2009 ◽  
Vol 00 (00) ◽  
pp. 090901052053001-8
Author(s):  
K. Murai ◽  
H. Yamazaki ◽  
K. Nakagawa ◽  
R. Kawai ◽  
T. Kamataki

2010 ◽  
Author(s):  
N. Magnavita ◽  
I. lavicoli ◽  
V. Leso ◽  
A. Bergamaschi

Sign in / Sign up

Export Citation Format

Share Document